Baxter International NEWS
Baxter starts phase 3 trial of new therapy for acute kidney injury
- Pharmaceutical Business ReviewBaxter
acute therapies medical director Farah Ali said: “One potential obstacle in delivering effective CRRT occurs when blood flow through the circuit is slowed or completely stopped by blood clots. “Extending the life of the extracorporeal circuit ...
Baxter International Inc. (NYSE:BAX) Analyst Estimates And Rating
- The Independent RepublicBaxter International
Inc. (NYSE:BAX) stock is presently standing at about $46.89 and lots of equity research firms seem to have a target price set on the stock. The median one-year price target of 12 analysts covering the company is $53.00, which ...
Baxter International Inc. (NYSE:BAX): Sell-Side Focus
- Transcript Daily
For the quarter ending 2016-12-31, analysts have $0.78 as the consensus EPS estimate for Baxter International
Inc. (NYSE:BAX). But on or around 2017-02-07, the company is expected to post its next earnings numbers. $0.56 is the last posted EPS, which ...
Baxter International Videos
Baxter International Inc - Why Invest in
Popular Videos - Peritoneal dialysis & Baxter International
Baxter International Inc. expanding operations in Mountain Home
Harry M. Kraemer, Former Chairman & CEO, Baxter International
Baxter International Projects, Budgets, Initiatives In The News
Baxter International - 2016 Corporations That Care Award
Baxter International by Aqeel and Manuel
Interview with Baxter Healthcare's Vice President for EHS and Sustainability
Baxter International Images
Baxter International WebSites
Welcome to Baxter. Learn how our groundbreaking medical products have saved and sustained lives for over 80 years
Baxter International Inc. is an American health care company with headquarters in Deerfield, Illinois. The company primarily focuses on products to treat hemophilia ...
Baxter International, Inc. produces and supplies specialized medical products, including biopharmaceuticals and medical equipment. It operates through two segments ...
Baxter SHARESOURCE Successfully Manages Home Dialysis Zacks Investment Research - Thu Oct 20, 1:15PM UTC; Baxter's Recently Launched SHARESOURCE Telehealth System Has ...
Stock analysis for Baxter International Inc (BAX:New York) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
Baxter International Inc. (BAX) develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney diseases ...
Baxter employees around the world are connected by an enduring commitment to save and sustain lives. Inspired by this mission, we have helped shape medicine as we ...
Keep up with the latest news and announcements at Baxter by browsing through our press release archives.
Canada Homepage of Baxter International Inc. ... Baxter International Foundation. Increasing access to healthcare in local and global communities
Baxter International Wiki
Baxter International Inc. is an American health care company with headquarters in Deerfield, Illinois. The company primarily focuses on products to treat hemophilia, kidney disease, immune disorders and other chronic and acute medical conditions. The company had 2013 sales of $16.3 billion, across two businesses: BioScience and Medical Products. Baxter’s BioScience business produces recombinant and blood plasma proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies and other chronic and acute blood-related conditions; products for regenerative medicine; and vaccines. Baxter’s Medical Products business produces intravenous solutions and other products used in the delivery of fluids and drugs to patients; inhalation anesthetics; contract manufacturing services; and products to treat end-stage renal disease, or irreversible kidney failure, including solutions and other products for peritoneal dialysis and hemodialysis.